港股异动 | 恒瑞医药(01276.HK)涨超3% 海曲泊帕乙醇胺片药品上市许可申请获国家药监局受理

智通财经
Aug 13
【港股异动 | 恒瑞医药(01276.HK)涨超3% 海曲泊帕乙醇胺片药品上市许可申请获国家药监局受理】智通财经APP获悉,恒瑞医药(01276.HK)涨超3%,截至发稿,涨3.19%,报77.75港元,成交额1.46亿港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10